FDA Publishes Its Draft Strategy Document on Innovative Manufacturing Technologies
FDA Law Blog
SEPTEMBER 16, 2024
Innovative manufacturing” is a somewhat ill-defined term, but the agency uses it to refer to any novel manufacturing that can increase product development speed, bolster supply chains, or prevent drug shortages. Regarding CBER’s CATT, the center is currently revising its internal procedures, referred to as CATT 2.0,
Let's personalize your content